Japan, Oct. 30 -- ALNYLAM PHARMACEUTICALS INC has got intellectual property rights for 'MULTI-TARGETED SINGLE ENTITY CONJUGATES.' Other related details are as follows:
Application Number: JP,2025-064720
Category (FI): C12N15/09,110,C12N15/113@Z,C12N15/11@Z
Stage: Grant (IP right granted following substantive examination.)
Filing Date: April 10, 2025
Publication Date: July 3, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
